mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
3e-06 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-06 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-06 |
mRNA |
vincristine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
8e-06 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
manumycin A |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-05 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
1e-05 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
1e-05 |